FGH-10019

N/A

Report date: 2025/01/26 17:42:59
NME

Base Information

Drug NameFGH-10019
Drug Alias NameFGH-10019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSterol regulatory element binding transcription factor 1 inhibitorsSterol regulatory element-binding protein 2 inhibitors
TargetsSterol regulatory element binding transcription factor 1Sterol regulatory element-binding protein 2
Therapy Area/IndicationsObesityMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFgh Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesFgh Biotech Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A